Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -87.68% is 875% below its 5-year average of -9.00%, near the low end of its 5-year range (-87.68%–16.49%).
As of the fiscal period ended Saturday, August 31, 2024. 78.83% below its 12-month average of -49.03%.
Annual fiscal-year return on equity; no daily interpolation.
RETURN ON EQUITY (ROE)
-87.68%
RETURN ON EQUITY (ROE) AVG TTM
-49.03%
RETURN ON EQUITY (ROE) AVG 3Y
-18.16%
RETURN ON EQUITY (ROE) AVG 5Y
-9.00%
RETURN ON EQUITY (ROE) AVG 10Y
1.45%
RETURN ON EQUITY (ROE) AVG 15Y
14.10%
RETURN ON EQUITY (ROE) AVG 20Y
14.99%
CURRENT VS TTM AVG
-78.83%
CURRENT VS 3Y AVG
-382.95%
CURRENT VS 5Y AVG
-874.76%
CURRENT VS 10Y AVG
-6154.49%
CURRENT VS 15Y AVG
-721.71%
CURRENT VS 20Y AVG
-684.84%
SECTOR MEDIAN · HEALTHCARE
10.89%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-905.14%
vs the sector median at left
Walgreens Boots Alliance, Inc.
Market Cap
$10.37B
Return on Equity (ROE)
-87.68%
TTM Avg
-49.03%
3Y Avg
-18.16%
5Y Avg
-9.00%
Market Cap
$10.21B
Return on Equity (ROE)
-0.17%
TTM Avg
18.91%
3Y Avg
22.60%
5Y Avg
24.60%
Market Cap
$10.20B
Return on Equity (ROE)
20.19%
TTM Avg
18.80%
3Y Avg
15.17%
5Y Avg
15.31%
Market Cap
$9.77B
Return on Equity (ROE)
12.09%
TTM Avg
11.88%
3Y Avg
12.69%
5Y Avg
13.50%
Market Cap
$11.20B
Return on Equity (ROE)
-6.28%
TTM Avg
-2.13%
3Y Avg
6.32%
5Y Avg
9.65%
Market Cap
$11.29B
Return on Equity (ROE)
5.25%
TTM Avg
5.98%
3Y Avg
10.62%
5Y Avg
11.34%
Market Cap
$11.45B
Return on Equity (ROE)
23.25%
TTM Avg
25.41%
3Y Avg
19.99%
5Y Avg
14.02%
Market Cap
$8.80B
Return on Equity (ROE)
2.46%
TTM Avg
-8.94%
3Y Avg
-15.72%
5Y Avg
1.14%
Market Cap
$12.11B
Return on Equity (ROE)
9.77%
TTM Avg
10.54%
3Y Avg
10.84%
5Y Avg
19.93%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Walgreens Boots Alliance, Inc. (WBA) | $10.37B | -87.68% | -49.03% | -18.16% | -9.00% |
| Molina Healthcare, Inc. (MOH)vs › | $10.21B | -0.17% | 18.91% | 22.60% | 24.60% |
| Universal Health Services, Inc. (UHS)vs › | $10.20B | 20.19% | 18.80% | 15.17% | 15.31% |
| Henry Schein, Inc. (HSIC)vs › | $9.77B | 12.09% | 11.88% | 12.69% | 13.50% |
| Charles River Laboratories International, Inc. (CRL)vs › | $11.20B | -6.28% | -2.13% | 6.32% | 9.65% |
| Bio-Techne Corporation (TECH)vs › | $11.29B | 5.25% | 5.98% | 10.62% | 11.34% |
| Insulet Corp. (PODD)vs › | $11.45B | 23.25% | 25.41% | 19.99% | 14.02% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.80B | 2.46% | -8.94% | -15.72% | 1.14% |
| Align Technology, Inc. (ALGN)vs › | $12.11B | 9.77% | 10.54% | 10.84% | 19.93% |
| Revvity, Inc. (RVTY)vs › | $12.55B | 3.35% | 3.59% | 3.35% | 7.68% |
ROE
-87.7%
ROA
-9.1%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2024-08-31 | -82.68% |
| 2023-08-31 | -15.38% |
| 2022-08-31 | 14.77% |
| 2021-08-31 | 10.67% |
| 2020-08-31 | 2.16% |
| 2019-08-31 | 16.49% |
| 2018-08-31 | 18.82% |
| 2017-08-31 | 14.42% |
| 2016-08-31 | 13.78% |
| 2015-08-31 | 13.48% |
| 2014-08-31 | 9.40% |
| 2013-08-31 | 13.10% |
| 2012-08-31 | 11.66% |
| 2011-08-31 | 18.28% |
| 2010-08-31 | 14.52% |
| 2009-08-31 | 13.95% |
| 2008-08-31 | 16.76% |
| 2007-08-31 | 18.38% |
| 2006-08-31 | 17.31% |
| 2005-08-31 | 17.54% |
| 2004-08-31 | 16.53% |
| 2003-08-31 | 16.34% |
| 2002-08-31 | 16.36% |
| 2001-08-31 | 17.01% |
| 2000-08-31 | 18.35% |
| 1999-08-31 | 17.91% |
| 1998-08-31 | 17.94% |
| 1997-08-31 | 18.37% |
| 1996-08-31 | 18.19% |
| 1995-08-31 | 17.90% |
